About Mindbloom

Mindbloom offers clinician-prescribed at-home ketamine therapy to treat anxiety, depression, and PTSD, utilizing neuroplasticity to facilitate personal and clinical breakthroughs. The program is designed to provide measurable relief, with 89% of participants in their largest study reporting significant improvements in mental health symptoms.

```xml <problem> Individuals experiencing anxiety, depression, and PTSD often face challenges accessing timely and effective mental health treatment due to factors such as stigma, cost, and limited availability of mental health professionals. Traditional treatment methods may not always provide sufficient relief or address the underlying causes of these conditions. </problem> <solution> Mindbloom provides clinician-prescribed, at-home ketamine therapy as a treatment option for individuals struggling with anxiety, depression, and PTSD. The program leverages the neuroplastic effects of ketamine to facilitate personal breakthroughs and measurable improvements in mental health symptoms. Through a combination of virtual consultations with licensed clinicians, personalized treatment plans, and guided at-home ketamine sessions, Mindbloom aims to offer a convenient and accessible alternative to traditional mental healthcare. The company emphasizes safety protocols and comprehensive support throughout the treatment process. </solution> <features> - Virtual consultations with licensed psychiatric clinicians to assess eligibility and develop personalized treatment plans - At-home ketamine therapy sessions with guidance and support from trained professionals - Integration of evidence-based practices, such as mindfulness and cognitive behavioral techniques, to enhance treatment outcomes - Progress tracking and monitoring to measure symptom reduction and overall well-being - Secure and confidential platform for communication and data management - Educational resources and community support to promote understanding and reduce stigma surrounding mental health treatment </features> <target_audience> The primary target audience includes adults experiencing symptoms of anxiety, depression, or PTSD who are seeking alternative or complementary treatment options and prefer the convenience of at-home therapy. </target_audience> ```

What does Mindbloom do?

Where is Mindbloom located?

Mindbloom is based in East New York, United States.

When was Mindbloom founded?

Mindbloom was founded in 2019.

How much funding has Mindbloom raised?

Mindbloom has raised 44900000.

Location

East New York, United States

Founded

2019

Funding

44900000

Employees

188 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Mindbloom

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

mindbloom.com 20K+

Crunchbase

Founded 2019 – East New York, United States

Funding

Estimated Funding

$20M+

Team (100+)

No team information available.

Company Description

Problem

Individuals experiencing anxiety, depression, and PTSD often face challenges accessing timely and effective mental health treatment due to factors such as stigma, cost, and limited availability of mental health professionals. Traditional treatment methods may not always provide sufficient relief or address the underlying causes of these conditions.

Solution

Mindbloom provides clinician-prescribed, at-home ketamine therapy as a treatment option for individuals struggling with anxiety, depression, and PTSD. The program leverages the neuroplastic effects of ketamine to facilitate personal breakthroughs and measurable improvements in mental health symptoms. Through a combination of virtual consultations with licensed clinicians, personalized treatment plans, and guided at-home ketamine sessions, Mindbloom aims to offer a convenient and accessible alternative to traditional mental healthcare. The company emphasizes safety protocols and comprehensive support throughout the treatment process.

Features

Virtual consultations with licensed psychiatric clinicians to assess eligibility and develop personalized treatment plans

At-home ketamine therapy sessions with guidance and support from trained professionals

Integration of evidence-based practices, such as mindfulness and cognitive behavioral techniques, to enhance treatment outcomes

Progress tracking and monitoring to measure symptom reduction and overall well-being

Secure and confidential platform for communication and data management

Educational resources and community support to promote understanding and reduce stigma surrounding mental health treatment

Target Audience

The primary target audience includes adults experiencing symptoms of anxiety, depression, or PTSD who are seeking alternative or complementary treatment options and prefer the convenience of at-home therapy.